Posted by William D Davis on Thursday, January 27, 2011,
In :
Health
The ASR XL Acetabular System and ASR Hip Resurfacing System are orthopedic hip replacement devices manufactured by DePuy and both were recalled from the worldwide market in August of 2010. It was discovered by a foreign joint registry that these implants inherently have flaws that contributed to its high failure rate. Components from the hip replacements rub together that cause metal ions such as cobalt and chromium to get scraped off and be absorbed by the body into the bloodstream. Some DeP... Continue reading ...
Posted by William D Davis on Tuesday, January 4, 2011,
In :
Health
There is definitely no doubt about it. DePuy Orthopaedics should issued a recall the moment they knew that their implants were defective. In fact, they should have never released their ASR implants to the market, because they never underwent clinical testing procedures set forth by the Food and Drug Administration in the United States. It was eventually found out that the ASR XL Acetabular System and the ASR Hip Resurfacing System both had a failure rate of 12-13%. It can also affect 1 in eve... Continue reading ...
Posted by William D Davis on Thursday, December 23, 2010,
In :
Law
DePuy Orthopaedics has manufactured their own patented brands of metal-on-metal hip implants, the ASR XL Acetabular System and the ASR Hip Resurfacing System, both of which have been deemed as defective and harmful for human use—at least most of them. Just this year, the controversial company announced a product recall on these hip implants as a response to the angry complaints of the recipients. Above all, DePuy is also willing to provide reimbursements to those who were affected. The quest... Continue reading ...
Posted by William D Davis on Tuesday, December 14, 2010,
In :
Health
Months have passed since the product recall was issued by DePuy Orthopaedics, a subsidiary of company giant Johnson & Johnson. Within this time frame, thousands have aired out their concerns regarding the defects of their hip implants, the ASR XL Acetabular System and the ASR Hip Resurfacing System, which both had a 13% failure rate. Typically, patients implanted with the faulty devices will experience pain, weakness and swelling in the hip region a few months or years after the hip replaceme... Continue reading ...
Posted by William D Davis on Friday, December 3, 2010,
In :
Law
Surgeries, being invasive procedures, have accompanying risks that are most likely to occur during the post-operative phase, when the patient is most vulnerable. Orthopedic surgeries are no exception, even if no internal organs are harmed. Hip replacements are commonly performed procedures, and the functionality of hip prosthetic devices implanted into the joints determines how a patient will react in the coming days.
The ideal duration for hip replacement patients to undertake rehabilitation ... Continue reading ...
Posted by William D Davis on Monday, November 29, 2010,
The Food and Drug Administration, a government department, is a branch responsible for ensuring the general public that all food, cosmetic and health care products for sale in the market are safe, hygienic and effective. That said, products from different manufacturers also hold the same responsibility in creating their products according to the set standards of safety, sanitation and effectiveness that the FDA strictly requires. Moreover, the FDA has regulatory processes to ensure that these... Continue reading ...
| |
